
a16z Capital Management, L.L.C.
About a16z Capital Management, L.L.C.’s 13F portfolio
a16z Capital Management, L.L.C. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , a16z Capital Management, L.L.C. reported $14.2B across 19 US-listed positions (). Its largest position is SPACE EXPLORATION TECHN CORP (SPCX) at 90% of the reported book, and its ten biggest holdings make up 99% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | TSX: SPCX SPACE EXPLORATION TECHN CORP | $138.43 −3.53% | 90% | 74.9M | $12.8B |
| 2 | NASDAQ: NAVN NAVAN INC | $24.33 −2.60% | 4.5% | 28.2M | $645.4M |
| 3 | NASDAQ: RVMD REVOLUTION MEDICINES INC | $159.43 −0.24% | 1.2% | 921K | $172.5M |
| 4 | NASDAQ: META META PLATFORMS INC | $596.22 −3.27% | 0.8% | 213K | $119.7M |
| 5 | NYSE: FIG FIGMA INC | $16.26 −6.17% | 0.8% | 6.0M | $108.2M |
| 6 | NASDAQ: BIOA BIOAGE LABS INC | $4.71 −1.26% | 0.6% | 3.2M | $79.2M |
| 7 | OTC: BSQKZ BLOCK INC | $84.51 0.00% | 0.5% | 1.0M | $77.3M |
| 8 | NASDAQ: ERAS ERASCA INC | $14.22 +3.34% | 0.4% | 2.9M | $52.4M |
| 9 | NASDAQ: MAZE MAZE THERAPEUTICS INC | $32.43 +3.94% | 0.4% | 1.7M | $50.8M |
| 10 | NASDAQ: DMRA DAMORA THERAPEUTICS INC | — — | 0.2% | 1.2M | $32.2M |
| 11 | NASDAQ: OMDA OMADA HEALTH INC | $12.50 −5.09% | 0.2% | 1.2M | $25.3M |
| 12 | NASDAQ: NAUT NAUTILUS BIOTECHNOLOGY INC | $2.17 −10.70% | 0.1% | 9.1M | $16.9M |
| 13 | NYSE: RBLX ROBLOX CORP | $46.35 −2.07% | 0.1% | 275K | $14.9M |
| 14 | NASDAQ: AKTS AKTIS ONCOLOGY INC | — — | 0.1% | 415K | $13.4M |
| 15 | NASDAQ: CAMP CAMP4 THERAPEUTICS CORP | $4.00 −2.44% | 0.1% | 2.1M | $9.3M |
| 16 | NYSE: BTGO BITGO HOLDINGS INC | — — | 0.0% | 666K | $3.5M |
| 17 | NASDAQ: KLRA KAILERA THERAPEUTICS INC | — — | 0.0% | 140K | $3.1M |
| 18 | NYSE: DNA GINKGO BIOWORKS HOLDINGS INC | $8.20 −2.84% | 0.0% | 109K | $1.1M |
| 19 | NASDAQ: IPST IP STRATEGY HOLDINGS INC | $1.62 −2.71% | 0.0% | 4K | $10K |
Showing the 19 largest positions reported in this 13F.
- Technology5.3%
- Healthcare2.9%
- Communication Services0.9%
- Financial Services0.0%
- NewSPCXSPACE EXPLORATION TECHN CORP—$12.8B
- NewRBLXROBLOX CORP—$14.9M
- NewKLRAKAILERA THERAPEUTICS INC—$3.1M
- NewIPSTIP STRATEGY HOLDINGS INC—$10K
- ReducedFIGFIGMA INC−62.6%$108.2M
- ReducedOMDAOMADA HEALTH INC−50.0%$25.3M
- ReducedNAUTNAUTILUS BIOTECHNOLOGY INC−48.7%$16.9M
- SoldIPSTIP STRATEGY HOLDINGS INC−100%—
Reading a16z Capital Management, L.L.C.’s 13F portfolio
a16z Capital Management, L.L.C.’s $14.2B 13F book is spread across 19 reported positions and is highly concentrated — its ten largest positions alone are 99% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are SPCX, NAVN, RVMD, META and FIG, led by SPACE EXPLORATION TECHN CORP (SPCX) at 90% of the portfolio. The heaviest sector exposure is Technology (5%), then Healthcare (3%).
What a16z Capital Management, L.L.C. changed last quarter
Between 2026-03-31 and Q2 2026, a16z Capital Management, L.L.C. was roughly balanced between buying and selling: it opened 4 new positions and added to 0 more, while trimming 3 and closing 1 outright. Against a 19-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was SPACE EXPLORATION TECHN CORP (SPCX), and its biggest reduction was FIGMA INC (FIG).
What a 13F does and doesn’t reveal
A 13F captures only a16z Capital Management, L.L.C.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names a16z Capital Management, L.L.C. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. a16z Capital Management, L.L.C.'s profile on this page is built directly from those filings.
How current is the 13F data on a16z Capital Management, L.L.C.'s page?
It reflects a16z Capital Management, L.L.C.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When a16z Capital Management, L.L.C. files its next quarterly report, this page refreshes automatically.
Can I see a16z Capital Management, L.L.C.'s complete list of holdings?
This page highlights a16z Capital Management, L.L.C.'s largest positions rather than all 19 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under a16z Capital Management, L.L.C.'s filings.
Does a 13F show everything a16z Capital Management, L.L.C. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of a16z Capital Management, L.L.C.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why a16z Capital Management, L.L.C. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

